Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

The tipping point

Accelerating biosimilar uptake through medical education

- PMLiVE

Cuttsy + Cuttsy appoints healthcare education specialist

Clare Mariconda joins the agency from Sorted Food

- PMLiVE

Takeda bags EU approval for Adcetris in lymphoma

Data shows the drug improves PFS and symptom burden in CTCL patients

Celgene building

Celgene reaches $9bn agreement to buy Juno

Acquires its blood cancer CAR-T candidate in the process

Merck to pilot digital behavioural change programme

Will work with US digital therapeutics firm Blue Mesa Health in diabetes

Academic-industry collaboration in the era of big data

A window on the UK

Bristol-Myers Squibb (BMS) building

BMS’ Yervoy picks up another indication in Europe

The EC licenses the immuno-oncology treatment for children with skin cancer

- PMLiVE

Glythera strengthens its scientific advisory board and appoints CSO

Dr Robert Lutz and Dr Jon Roffey join the UK biotech

Swiss biotech Inositec appoints new chief medical officer

Dr Frits van Alphen joins the group from Roche

- PMLiVE

Amgen and Allergan win first EU approval for Avastin biosimilar

Mvasi, their version of Roche's blockbuster, is licensed for six types of cancers

Sanofi reception

Third time lucky? Sanofi cuts an $11.6bn deal to buy Bioverativ

French pharma firm offers $105 apiece for the spin-out’s shares

Biogen Idec building

NICE finally starts review of Biogen’s Spinraza for SMA

Will evaluate the treatment based on its Single Technology Appraisal process

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links